+44 (0)1223 330484


Dr. Mohib Uddin is a Biomedical Scientist with over a decade of global pharmaceutical experience in the development of biopharmaceutical therapies. Mohib graduated with a BSc degree in Pharmacology from the University of London, King’s College. He gained his PhD degree in Medicine at the University of Cambridge studying the enigmatic biology of the neutrophil as a college student at Hughes Hall. Later, he was awarded a Research Fellowship from the British Lung Foundation and subsequently held an international Fellowship in Pulmonary Medicine at the Harvard Medical School (USA).

Mohib’s translational research interests focus on the cellular and molecular mechanisms of lung disease to develop novel therapies for refractory airway disorders. His ambition is to make a meaningful impact on the clinical outcome for patients with unmet needs and thereby their families, communities and the wider global health.

He mentors, supervises and collaborates with various institutions, including the Cambridge Judge Business School, University of College London and the Medical Research Council, supporting the development of future Biomedical Scientists. Since 2019, he has been supporting Hughes Hall’s interest in advancing the global health research translation and impact via ‘The Bridge’ initiative, as well as the Hughes Hall Enterprise Society.
He enjoys travel and running and has completed the London and Paris Marathons to fundraise for national children’s charities, including Get Kids Going. He is attempting to write his first children’s book with the assistance of his son and daughter.